Pathology, clinical features and treatments of congenital copper metabolic disorders - Focus on neurologic aspects

Brain and Development

Volumn 33, Issue 3, 2011, Pages 243-251

  Kodama, Hiroko ^a   Fujisawa, Chie ^a   Bhadhprasit, Wattanaporn ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ATP7A; ATP7B; Copper; Menkes disease; Neurologic diseases; Occipital horn syndrome; Wilson's disease

Indexed keywords

CHELATING AGENT; COPPER; TETRATHIOMOLYBDIC ACID; ZINC;

CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COPPER METABOLISM; GENE MUTATION; GENETIC DISORDER; HUMAN; MENKES SYNDROME; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL HORN DISEASE; REVIEW; WILSON DISEASE;

CHILD; COPPER; HEPATOLENTICULAR DEGENERATION; HOMEOSTASIS; HUMANS; MENKES KINKY HAIR SYNDROME; METAL METABOLISM, INBORN ERRORS; NERVOUS SYSTEM DISEASES;

EID: 79251648024     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2010.10.021     Document Type: Review

References (36)

1. Kodama H., Fujisawa C. Copper metabolism and inherited copper transport disorders: molecular mechanisms, screening, and treatment. Metallomics 2009, 1:42-52.
2. Lutsenko S., Barnes N.L., Bartee M.Y., Dmitriev O.Y. Function and regulation of human copper-transporting ATPases. Physiol Rev 2007, 87:1011-1046.
3. de Bie P., Muller P., Wijmenga C., Klomp L.W. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 2007, 44:673-688.
4. Moller L.B., Mogensen M., Horn N. Molecular diagnosis of Menkes disease: genotype-phenotype correlation. Biochimie 2009, 91:1273-1277.
5. Gu Y.H., Kodama H., Shiga K., Nakata S., Yanagawa Y., Ozawa H. A survey of Japanese patients with Menkes disease from 1990 to 2003: incidence and early signs before typical symptomatic onset, pointing the way to earlier diagnosis. J Inherit Metab Dis 2005, 28:473-478.
6. Gu Y.H., Kodama H., Murata Y., Mochizuki D., Yanagawa Y., Ushijima H., et al. ATP7A gene mutations in 16 patients with Menkes disease and a patient with occipital horn syndrome. Am J Med Genet 2001, 99:217-222.
7. Kodama H. Gene defects and clinical aspects in Menkes disease and occipital hornsyndrom. Handbook of Copper Pharmacology 2002, 319-338. Human Press, Totowa, USA. E. Massaro (Ed.).
8. Agertt F., Crippa A.C., Lorenzoni P.J., Scola R.H., Bruck I., Paola L., et al. Menkes's disease: case report. Arq Neuropsiquiatr 2007, 65:157-160.
9. Bahi-Buisson N., Kaminska A., Nabbout R., Barnerias C., Desguerre I., De Lonlay P., et al. Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia 2006, 47:380-386.
10. Ozawa H., Otaki U., Gu Y.H., Kodama H. The symptoms and treatment of 20 patients with Menkes disease in Japan (in Japanese). Nihon Shonika Gakkai Zasshi (Tokyo) 2009, 113:1234-1237.
11. Ito H., Mori K., Sakata M., Naito E., Harada M., Minato M., et al. Pathophysiology of the transient temporal lobe lesion in a patient with Menkes disease. Pediatr Int 2008, 50:825-827.
12. Ozawa H., Kodama H., Murata Y., Takashima S., Noma S. Transient temporal lobe changes and a novel mutation in a patient with Menkes disease. Pediatr Int 2001, 43:437-440.
13. Gu Y.H., Kodama H., Sato E., Mochizuki D., Yanagawa Y., Takayanagi M., et al. Prenatal diagnosis of Menkes disease by genetic analysis and copper measurement. Brain Dev 2002, 24:715-718.
14. Sarkar B., Lingertat-Walsh K., Clarke J.T. Copper-histidine therapy for Menkes disease. J Pediatr 1993, 123:828-830.
15. Christodoulou J., Danks D.M., Sarkar B., Baerlocher K.E., Casey R., Horn N., et al. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. Am J Med Genet 1998, 76:154-164.
16. Kaler S.G., Holmes C.S., Goldstein D.S., Tang J., Godwin S.C., Donsante A., et al. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med 2008, 358:605-614.
17. Kodama H., Sato E., Gu Y.H., Shiga K., Fujisawa C., Kozuma T. Effect of copper and diethyldithiocarbamate combination therapy on the macular mouse, an animal model of Menkes disease. J Inherit Metab Dis 2005, 28:971-978.
18. Mak C.M., Lam C.W. Diagnosis of Wilson's disease: a comprehensive review. Crit Rev Clin Lab Sci 2008, 45:263-290.
19. Gu Y.H., Kodama H., Du S.L., Gu Q.J., Sun H.J., Ushijima H. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease. Clin Genet 2003, 64:479-484.
20. Panagiotakaki E., Tzetis M., Manolaki N., Loudianos G., Papatheodorou A., Manesis E., et al. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). Am J Med Genet A 2004, 131:168-173.
21. Gromadzka G., Schmidt H.H., Genschel J., Bochow B., Rodo M., Tarnacka B., et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Clin Genet 2005, 68:524-532.
22. Barada K., El-Atrache M., El-Haji I.I., Rida K., El-Hajjiar J., Mahfound Z., et al. Homozygous mutations in the conserved ATP hinge region of the Wilson disease gene. J Clin Gastroenterol 2010, 44:432-439.
23. Lorincz M.T. Neurologic Wilson's disease. Ann N Y Acad Sci 2010, 1184:173-187.
24. Prashanth L.K., Sinha S., Taly A.B., Mahadevan A., Vasudev M.K., Shankar S.K. Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates. J Neurol Sci 2010, 15:44-51.
25. Pestana Knight E.M., Gilman S., Selwa L. Status epilepticus in Wilson's disease. Epileptic Disord 2009, 11:138-143.
26. Kodama H., Okabe I., Yanagisawa M., Nomiyama H., Nomiyama K., Nose O., et al. Does CSF copper level in Wilson disease reflect copper accumulation in the brain?. Pediatr Neurol 1988, 4:35-37.
27. Sinha S., Taly A.B., Prashanth L.K., Ravishankar S., Arunodaya G.R., Vasudev M.K. Sequential MRI changes in Wilson's disease with de-copper therapy: a study of 50 patients. Br J Radiol 2007, 80:744-749.
28. Ferenci P., Caca K., Loudianos G., Mieli-Vergani G., Tanner S., Sternlieb I., et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003, 23:139-142.
29. Roberts E.A., Schilsky M.L. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008, 47:2089-2111.
30. Brewer G.J. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS Drugs 2005, 19:185-192.
31. Brewer G.J., Askari F., Lorincz M.T., Carlson M., Schilsky M., Kluin K.J., et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2006, 63:521-527.
32. Brewer G.J., Askari F.K. Wilson's disease: clinical management and therapy. J Hepat 2005, 42:S13-S21.
33. Prashanth L.K., Taly A.B., Sinha S., Arunodaya G.R., Swamy H.S. Wilson's disease: diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry 2004, 75:907-909.
34. Komatsu H., Fujisawa T., Inui A., Sogo T., Sekine I., Kodama H., et al. Hepatic copper concentration in children undergoing living related liver transplantation due to Wilsonian fulminant hepatic failure. Clin Transplant 2002, 16:227-232.
35. Duarte-Rojo A., Zepeda-Gomez S., Garcia-Leiva J., Remes-Troche J.M., Angeles-Angeles A., Torre-Delgadillo A., et al. Liver transplantation for neurologic Wilson's disease: reflections on two cases within a Mexican cohort. Rev Gastroenterol Mex 2009, 74:218-223.
36. Das S.K., Ray K. Wilson's disease: an update. Nat Clin Pract Neurol 2006, 2:482-493.